Product Information
LEVOTHYROXINE 175 MCG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0765 per EA under NDC 31722029310. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Jan 18, 2023. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.175 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722029310
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA215259FDA Approved
1/18/2023
TE Code
AB4
On Market Since
1/18/2023
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 175 MCG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 33.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0765 per EA |
|---|---|
| All-time high | $0.1267 (Feb 14, 2024) |
| All-time low | $0.0711 (May 22, 2024) |
| 52-week high | $0.1060 |
| 52-week low | $0.0765 |
| Median price | $0.0932 |
| Average price | $0.0946 |
| Largest weekly change | +48.2% (Aug 21, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 175 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 175 MCG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0765 per EA (NDC 31722029310), effective Aug 19, 2026.
How has the price of LEVOTHYROXINE 175 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 175 MCG TABLET has declined 33.7%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 175 MCG TABLET?
Since Oct 11, 2023, the NADAC for LEVOTHYROXINE 175 MCG TABLET has ranged from a low of $0.0711 (May 22, 2024) to a high of $0.1267 (Feb 14, 2024), with a median of $0.0932 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 175 MCG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 175 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 175 MCG TABLET?
LEVOTHYROXINE 175 MCG TABLET (NDC 31722029310) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.